Related Experiment Video
Updated: Mar 22, 2026

Graphene Coatings for Biomedical Implants
Published on: March 1, 2013
Molecular interactions of graphene oxide with human blood plasma proteins
Kenry1, Kian Ping Loh2, Chwee Teck Lim3
1NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore 117456, Singapore. ctlim@nus.edu.sg and Centre for Advanced 2D Materials and Graphene Research Centre, National University of Singapore, Singapore 117543, Singapore and Department of Biomedical Engineering, National University of Singapore, Singapore 117575, Singapore.
Abstract:
We investigate the molecular interactions between graphene oxide (GO) and human blood plasma proteins. To gain an insight into the bio-physico-chemical activity of GO in biological and biomedical applications, we performed a series of biophysical assays to quantify the molecular interactions between GO with different lateral size distributions and the three essential human blood plasma proteins. We elucidate the various aspects of the GO-protein interactions, particularly, the adsorption, binding kinetics and equilibrium, and conformational stability, through determination of quantitative parameters, such as GO-protein association constants, binding cooperativity, and the binding-driven protein structural changes. We demonstrate that the molecular interactions between GO and plasma proteins are significantly dependent on the lateral size distribution and mean lateral sizes of the GO nanosheets and their subtle variations may markedly influence the GO-protein interactions. Consequently, we propose the existence of size-dependent molecular interactions between GO nanosheets and plasma proteins, and importantly, the presence of specific critical mean lateral sizes of GO nanosheets in achieving very high association and fluorescence quenching efficiency of the plasma proteins. We anticipate that this work will provide a basis for the design of graphene-based and other related nanomaterials for a plethora of biological and biomedical applications.
More Related Videos
Related Concept Videos
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
Drug Distribution: Plasma Protein Binding
Composition of Blood Plasma
Oxygen Transport in the Blood
Glycocalyx and its Functions

